Changho Han

Title: Changho Han: Innovator in Pharmaceutical Compounds

Introduction

Changho Han is a prominent inventor based in Nashville, TN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific biological interactions. With a total of 8 patents to his name, Han's work is paving the way for advancements in medical treatments.

Latest Patents

Among his latest patents, Han has developed WDR5-MYC inhibitors, which are substituted N-phenyl sulfonamide compounds that inhibit WDR5-MYC interactions. These compounds and their pharmaceutical compositions are particularly useful for treating disorders and conditions in subjects, such as cancer cell proliferation. Another notable patent involves antagonists of the muscarinic acetylcholine receptor M4. This patent discloses substituted hexahydro-1H-cyclopenta[c]pyrrole compounds, which may serve as antagonists of the muscarinic acetylcholine receptor M(mAChR M). The patent also includes methods of making these compounds, pharmaceutical compositions comprising them, and methods of treating disorders using these compounds and compositions.

Career Highlights

Changho Han has worked with esteemed institutions such as Vanderbilt University and Purdue Research Foundation. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Joseph R Alvarado and Shaun R Stauffer. Their collaborative efforts have further enhanced the impact of Han's inventions in the pharmaceutical industry.

Conclusion

Changho Han's innovative work in developing pharmaceutical compounds demonstrates his commitment to advancing medical science. His patents reflect a deep understanding of complex biological interactions and their potential therapeutic applications.